Gaia, Silvia

Publishing since 1998 (Senior)

Has published 13 publications in 11 years

Number of publications published per year by Gaia, Silvia. (Source : PubMed)

Distribution of publications types for Gaia, Silvia. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Gaia S, Barbon V, Smedile A, Olivero A, Carenzi S, Lagget M, Alessandria C, Rizzetto M, Marzano A. Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine.  J. Hepatol.  2008;48;4  
•  Gaia S, Cappia S, Smedile A, Bacillo E, Gaia E, Gubetta L, Rizzetto M. Epithelial microchimerism: consistent finding in human liver transplants.  J. Gastroenterol. Hepatol.  2006;21;12  
•  Gaia S, Smedile A, Omedè P, Olivero A, Sanavio F, Balzola F, Ottobrelli A, Abate ML, Marzano A, Rizzetto M, Tarella C. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.  J. Hepatol.  2006;45;1  
•  Olivero A, Ciancio A, Abate ML, Gaia S, Smedile A, Rizzetto M. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.  J. Viral Hepat.  2006;13;6  
•  Gaia S, Bruno M, Marzano A, Novero D, Astegiano M, Actis GC, Rizzetto M. A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies.  Panminerva Med  2005;47;4  
•  Gaia S, Marzano A, Olivero A, Abate M, Rizzetto M, Smedile A. Inactive hepatitis B virus carriers: a favourable clinical condition.  Eur J Gastroenterol Hepatol  2005;17;12  
•  Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, Alessandria C, Franchello A, Salizzoni M, Rizzetto M. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.  Liver Transpl.  2005;11;4  
•  Barbon V, Gaia S, Marzano A, Lagget M, Rizzetto M. Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy.  J. Hepatol.  2004;41;3  
•  Gaia S, Marzano A, Smedile A, Barbon V, Abate ML, Olivero A, Lagget M, Paganin S, Fadda M, Niro G, Rizzetto M. Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B.  Aliment. Pharmacol. Ther.  2004;20;3  
•  Alessandria C, Gaia S, Marzano A, Venon WD, Fadda M, Rizzetto M. Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment.  Eur J Gastroenterol Hepatol  2004;16;6  

[ See timeline ] [ See all publications ]